AU Patent

AU2015331599B2 — Wearable automatic injection system and apparatus

Assigned to AbbVie Inc · Expires 2020-11-05 · 6y expired

What this patent protects

A wearable automatic injection device is provided for administering a final medicament to a patient. The wearable automatic injection device comprises a housing (105c), an injection assembly (120c) for injecting the patient with the final medicament, a container holding a bulk in…

USPTO Abstract

A wearable automatic injection device is provided for administering a final medicament to a patient. The wearable automatic injection device comprises a housing (105c), an injection assembly (120c) for injecting the patient with the final medicament, a container holding a bulk intermediate medicament and a diluent to be mixed to form the medicament, and a mixing mechanism for mixing the bulk intermediate medicament and the diluent in the container (125c) to form the final medicament prior. A system for administering a final medicament to a patient is also provided. The system comprises a container, a mixing mechanism for mixing a bulk intermediate medicament and a diluent in the container to form the final medicament, and a wearable automatic injection device configured to receive the container.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015331599B2
Jurisdiction
AU
Classification
—
Expires
2020-11-05
Drug substance claim
No
Drug product claim
No
Assignee
AbbVie Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.